Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma.
Choueiri TK, Motzer RJ, Rini BI, Haanen J, Campbell MT, Venugopal B, Kollmannsberger C, Gravis-Mescam G, Uemura M, Lee JL, Grimm MO, Gurney H, Schmidinger M, Larkin J, Atkins MB, Pal SK, Wang J, Mariani M, Krishnaswami S, Cislo P, Chudnovsky A, Fowst C, Huang B, di Pietro A, Albiges L. Choueiri TK, et al. Among authors: uemura m. Ann Oncol. 2020 Aug;31(8):1030-1039. doi: 10.1016/j.annonc.2020.04.010. Epub 2020 Apr 25. Ann Oncol. 2020. PMID: 32339648 Free PMC article. Clinical Trial.
C4.4A expression is associated with a poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M, Yamamoto H, Masuzawa T, Takahashi H, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki M, Miyata H, Takemasa I, Mizushima T, Takiguchi S, Doki Y, Mori M. Ohtsuka M, et al. Among authors: uemura m. Ann Surg Oncol. 2013 Aug;20(8):2699-705. doi: 10.1245/s10434-013-2900-2. Epub 2013 Feb 24. Ann Surg Oncol. 2013. PMID: 23435632
Concurrent expression of C4.4A and Tenascin-C in tumor cells relates to poor prognosis of esophageal squamous cell carcinoma.
Ohtsuka M, Yamamoto H, Oshiro R, Takahashi H, Masuzawa T, Uemura M, Haraguchi N, Nishimura J, Hata T, Yamasaki M, Takemasa I, Miyata H, Mizushima T, Takiguchi S, Doki Y, Mori M. Ohtsuka M, et al. Among authors: uemura m. Int J Oncol. 2013 Aug;43(2):439-46. doi: 10.3892/ijo.2013.1956. Epub 2013 May 24. Int J Oncol. 2013. PMID: 23708783
Prognostic Impact of Lateral Pelvic Node Dissection on the Survival of Patients in Low Rectal Cancer Subgroups Based on Lymph Node Size.
Hida K, Nishizaki D, Sumii A, Okamura R, Sakai Y, Konishi T, Akagi T, Yamaguchi T, Akiyoshi T, Fukuda M, Yamamoto S, Arizono S, Uemura M, Hasegawa H, Kawada K, Morita S, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery. Hida K, et al. Among authors: uemura m. Ann Surg Oncol. 2021 Oct;28(11):6179-6188. doi: 10.1245/s10434-021-10312-7. Epub 2021 Jul 13. Ann Surg Oncol. 2021. PMID: 34255243
Functional assessment of miR‑1291 in colon cancer cells.
Wang J, Yokoyama Y, Hirose H, Shimomura Y, Bonkobara S, Itakura H, Kouda S, Morimoto Y, Minami K, Takahashi H, Shibata S, Kobayashi S, Uemura M, Tanaka S, Wu X, Tanaka S, Mori M, Yamamoto H. Wang J, et al. Among authors: uemura m. Int J Oncol. 2022 Feb;60(2):13. doi: 10.3892/ijo.2022.5303. Epub 2022 Jan 4. Int J Oncol. 2022. PMID: 34981812 Free PMC article.
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal Cancer.
Bando H, Tsukada Y, Inamori K, Togashi Y, Koyama S, Kotani D, Fukuoka S, Yuki S, Komatsu Y, Homma S, Taketomi A, Uemura M, Kato T, Fukui M, Wakabayashi M, Nakamura N, Kojima M, Kawachi H, Kirsch R, Yoshida T, Suzuki Y, Sato A, Nishikawa H, Ito M, Yoshino T. Bando H, et al. Among authors: uemura m. Clin Cancer Res. 2022 Mar 15;28(6):1136-1146. doi: 10.1158/1078-0432.CCR-21-3213. Clin Cancer Res. 2022. PMID: 35063964 Free PMC article.
1,261 results